Kedokteran & Kesehatan editorial
Open AccessOA2025
The Current Landscape of Clinical Trials
This digest analyzes clinical trials registered on ClinicalTrials.gov, highlighting a continuous increase in registrations peaking in 2021 due to COVID-19, a focus on cancer, and persistent challenges in diversity, global distribution, and reporting.
Geeta Joshi; Tara K. Bhandari; P. Joshi; Smriti Bhandari; Shalini Reddy Araveeti; Aditi Jain; Subash Khadka; Shaun Trecarten; Ahmad Abdelaziz; Harshit Garg; Mukund Bhandariยท Journal of Clinical Medicineยท 2025ยท DOI 10.3390/jcm14072519
The core problem
Clinical trials are fundamental to the development of new medical treatments, providing essential data on safety and efficacy. This study examines the current landscape of clinical trials registered on ClinicalTrials.gov, identifying patterns, challenges, and innovations that have shaped the field over the past century. The objective is to provide a comprehensive overview of trial design, sponsorship, participant demographics, and geographical distribution, and to highlight areas needing improvement.
Innovation
Data were extracted from ClinicalTrials.gov on 7 March 2025. The analysis focused on trial registrations, study designs, sponsorship types, participant demographics, and geographical locations. Patterns and trends were identified using descriptive statistics and temporal analysis.
Introduction
Clinical trials are fundamental to the development of new medical treatments, providing essential data on safety and efficacy. This study examines the current landscape of clinical trials registered on ClinicalTrials.gov, identifying patterns, challenges, and innovations that have shaped the field over the past century. The objective is to provide a comprehensive overview of trial design, sponsorship, participant demographics, and geographical distribution, and to highlight areas needing improvement.
Why it matters
The findings underscore the need for more inclusive and globally distributed research to address disparities in health outcomes. The underrepresentation of key populations limits the generalizability of trial findings. Additionally, the lack of reporting of results hinders transparency and slows scientific progress. Innovations in trial design and increased awareness of diversity are steps toward addressing these issues, but concerted efforts are required to ensure that clinical trials reflect the populations they aim to serve.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ